Sudden cardiac death: Prevention when is right? From evidence-based medicine to family-based medicine;La morte cardiaca improvvisa: Prevenzione, quando opportuno! Da evidence-based medicine a family-based medicine

Giornale Italiano di Cardiologia

Volumn 7, Issue 3, 2006, Pages 224-227

  Paperini, Luca ^a   Genovesi, Alberto ^a   Carluccio, Marisa ^a  

^a Azienda USL 6   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANTIHYPERTENSIVE AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; PROPANOLAMINE DERIVATIVE; VASODILATOR AGENT;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; EVIDENCE BASED MEDICINE; FAMILY MEDICINE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART VENTRICLE FAILURE; HUMAN; MORTALITY; PRESCRIPTION; PRIMARY PREVENTION; RISK REDUCTION; SUDDEN DEATH; TREATMENT INDICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EUROPE; GENERAL PRACTICE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UNITED STATES; UTILIZATION REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARBAZOLES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; HUMANS; PROPANOLAMINES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; STROKE VOLUME; UNITED STATES; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645743425     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40.
2. Bardy GH, Lee KL, Mark DB, et al, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
3. Botto GL, Proclemer A, Luzi M, Ruffa F, Gorgoglione MG, Ferrari G. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation. Ital Heart J 2005; 6: 210-5.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-90.
5. Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
6. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004; 44: 2166-72.
7. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
8. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
9. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
10. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55.
11. Steinbrook R. The controversy over Guidant's implantable defibrillators. N Engl J Med 2005; 353: 221-4.
12. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353: 1471-80.
13. Swedberg H, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). http://www.escardio.org/knowledge/guidelines/Chronic_Heart_Failure.htm
14. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 guidelines for the evaluation and management of heart failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
15. Prystowsky EN. Primary prevention of sudden cardiac death: the time of your life. Circulation 2004; 109: 1073-5.